The Pharmacy Times® Coronavirus Disease Resource Center is a comprehensive resource for clinical news and expert insights on COVID-19, an infectious disease caused by the SARS-CoV-2 virus, including vaccine information and treatments for the disease.
May 3rd 2024
Additionally, undocumented Latinx patients were also more likely to have at least 1 prior COVID-19 infection.
April 24th 2024
Multiple state and federal laws since the COVID-19 pandemic highlight the growing role of technicians
April 14th 2024
Pandemic-related growing pains were common within health care, bringing unique challenges for health systems.
March 25th 2024
The indication is for adults and adolescents with moderate to severe immune compromise due to medical conditions or immunosuppressive medications and treatments.
March 20th 2024
Regardless, hygiene practices and prevention measures for SARS-CoV-2 should be strongly practiced to prevent all respiratory viruses.
Reducing Barriers Associated With Pneumococcal Vaccine Uptake
1.5 Credits / Immunization, Infectious Diseases
View More
Reducing the Incidence and Severity of RSV in Older Adults: Opportunities for Patient Identification and Vaccination Counseling
1.0 Credit / Infectious Diseases, Pulmonology/Respiratory
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Vaccine-Preventable Diseases: Strategies for Addressing Vaccine Hesitancy and Improving Vaccine Confidence
1.0 Credit / Immunization
View More
The Expanding Landscape of Vaccinations for the Prevention of Pneumococcal Disease: The Role of the Pharmacist as Patient Educator and Vaccinator
1.0 Credit / Pneumococcal Disease
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Examining the Evidence for Emerging Vaccines to Prevent RSV-Related Complications in Older Adults
2.0 Credits / Infectious Diseases, Respiratory, Immunization
View More
Influenza Prevention in the At-Risk Adult Population and the Pharmacist's Role in an Evolving Influenza Vaccine Landscape
1.25 Credits / Immunization, Infectious Disease
View More
Identifying Candidates for Meningococcal Vaccines (Pharmacy Technician Credit)
2.0 Credits / Immunization
View More
Identifying Candidates for Meningococcal Vaccines (Pharmacist Credit)
2.0 Credits / Immunization
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
The Pharmacist’s Impact on Shingles Prevention Through Vaccination: Recommendations, Uptake, and Improved Outcomes
1.5 Credits / Immunization
View More
Pharmacies Across Country Adjusting Services for High-Risk, Senior Citizen Shoppers
March 30th 2020Following the precautions many grocery stores across the nation have taken, various pharmacies in the United States are altering their hours and other services to cater to high-risk and senior citizen shoppers due to concerns surrounding the coronavirus disease 2019 (COVID-19) spread.
Read More
Compounders Ask FDA for More Guidance on Hand Sanitizer, Launch Donation Campaign
March 30th 2020The letter was issued by the American Pharmacists Association, the Alliance for Pharmacy Compounding, the National Community Pharmacists Association, and the National Alliance of State Pharmacy Associations.
Read More
Pharmacist in Action: COVID-19 Preparedness
March 27th 2020Curtis E. Haas, PharmD, FCCP, editor-in-chief of Pharmacy Times: Directions in Health-System Pharmacy, and chief pharmacy officer for the University of Rochester’s health care system, discusses preparation for potential patient surge due to COVID-19.
Watch
NCPA Hosts Tele-Conference to Discuss Importance of Pharmacists During COVID-19 Pandemic
March 27th 2020More than 1800 members registered for the town hall-style meeting, during which Rep. Buddy Carter (R-GA), a pharmacist and congressman, briefed attendees about emergency relief efforts currently in development by policymakers, efforts to address pharmacy direct and indirect remuneration (DIR) fees, and other key issues.
Read More
Potential COVID-19 Treatment Granted Orphan Drug Status
March 25th 2020While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.
Read More
FDA Takes Action to Increase US Supplies of PPE, Devices to Combat COVID-19
March 25th 2020The FDA released a statement on taking action to increase US supplies to support the response to the coronavirus disease 2019 by providing instructions to manufacturers importing personal protective equipment and other devices.
Read More
AI Turns Coughing Sounds into Health Data for Flu, Pandemic Forecasting
March 25th 2020The new edge-computing platform may expand the arsenal of health surveillance tools used to forecast seasonal flu and other viral respiratory outbreaks, such as COVID-19 or severe acute respiratory syndrome.
Read More
2 Commerce Drive
Cranbury, NJ 08512